SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) informs about disclosure

21 Feb 2025 Evaluate
In response to the mail dated 21 February, 2025 received from BSE regarding an intimation uploaded on 20.02.2025 to furnish additional information that is Date of receipt of order as per ‘Circular dated November 11, 2024, for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015’, Syschem (India) has informed that the company submitting again the disclosure with additional information as required under regulation 30 of SEBI (Listing Obligations and Disclosure requirement. They are also providing details as required to be disclosed in line with Clause 8.1 of SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

50.91 1.53 (3.10%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×